Angion Biomedica Corp Analysis
Angion Biomedica Corp is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Angion Biomedica delisted stock analysis is to determine its intrinsic value, which is an estimate of what Angion Biomedica Corp is worth, separate from its market price. There are two main types of Angion Biomedica's stock analysis: fundamental analysis and technical analysis.
The Angion Biomedica stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Angion Biomedica is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Angion Stock trading window is adjusted to America/New York timezone.
Angion |
Angion Stock Analysis Notes
About 33.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.49. Some equities with similar Price to Book (P/B) outperform the market in the long run. Angion Biomedica Corp recorded a loss per share of 10.11. The entity had not issued any dividends in recent years. Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company was incorporated in 1998 and is based in Uniondale, New York. Angion Biomedica operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 37 people. For more info on Angion Biomedica Corp please contact MBA MD at 415 655 4899 or go to https://www.angion.com.Angion Biomedica Corp Investment Alerts
| Angion Biomedica is not yet fully synchronised with the market data | |
| Angion Biomedica has some characteristics of a very speculative penny stock | |
| Angion Biomedica has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 2.3 M. Net Loss for the year was (38.81 M) with loss before overhead, payroll, taxes, and interest of (15.8 M). | |
| Angion Biomedica Corp currently holds about 63.37 M in cash with (38.39 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.1. | |
| Roughly 33.0% of the company shares are held by company insiders |
Angion Biomedica Corp Upcoming and Recent Events
Earnings reports are used by Angion Biomedica to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 21st of August 2023 Upcoming Quarterly Report | View | |
| 13th of November 2023 Next Financial Report | View | |
| 30th of June 2023 Next Fiscal Quarter End | View | |
| 31st of March 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Angion Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 30.11 M.Angion Biomedica Outstanding Bonds
Angion Biomedica issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Angion Biomedica Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Angion bonds can be classified according to their maturity, which is the date when Angion Biomedica Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Angion Biomedica to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Global Markets Map Now
Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in Angion Stock
If you are still planning to invest in Angion Biomedica Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Angion Biomedica's history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |